News

What Does the Market Think About Globus Medical?
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
Investor's Business Daily on MSN1d
Globus Medical Sees Relative Strength Rating Improve To 73
Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...
StockStory.org on MSN1d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?
Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
Globus Medical: Digesting Another Acquisition
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
Nasdaq15d
Breaking Down Globus Medical: 5 Analysts Share Their Views
Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...
Investing16d
JMP maintains Market Perform on Globus Medical stock
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts' stance ...